Studies have described the frequent activation of insulin receptor (InsR) and IGF-1R in GBM specimens and PDX cells at conferring resistance to EGFR inhibitors43–45, both frequently activated but rarely amplified or mutated in GBM according to TCGA (<2%)46. The gene discussed is EGFR; the disease is glioblastoma.